Peripheral Serum Exosomes Isolated from Patients with Acute Myocardial Infarction Promote Endothelial Cell Angiogenesis via the miR-126-3p/TSC1/mTORC1/HIF-1α Pathway
Shasha Duan,Chao Wang,Xiangli Xu,Xiaoshan Zhang,Gaofeng Su,You Li,Shuai Fu,Ping Sun,Jiawei Tian
DOI: https://doi.org/10.2147/ijn.s338937
IF: 7.033
2022-04-02
International Journal of Nanomedicine
Abstract:Shasha Duan, 1– 3, &ast Chao Wang, 1, 2, &ast Xiangli Xu, 4 Xiaoshan Zhang, 3 Gaofeng Su, 1, 2 You Li, 1, 2 Shuai Fu, 1, 2 Ping Sun, 1, 2 Jiawei Tian 1 1 Department of Ultrasound, the Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, People's Republic of China; 2 The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, Heilongjiang Province, People's Republic of China; 3 Department of Ultrasound, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, People's Republic of China; 4 Department of Ultrasound, the Second Hospital of Harbin city, Harbin, Heilongjiang Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jiawei Tian; Ping Sun, Department of Ultrasound, the Second Affiliated Hospital of Harbin Medical University, No. 246 Xuefu Road, Nangang District, Harbin, Heilongjiang Province, 150086, People's Republic of China, Tel +86 451-86605811, Fax +86 451-86605745, Email ; Purpose: Angiogenesis is required for improving myocardial function and is a key factor in long-term prognosis after an acute myocardial infarction (AMI). Although exosomes are known to play a crucial role in angiogenesis, the role of peripheral exosomes in angiogenic signal transduction in patients with AMI remains unclear. Here, we explored the effect of exosomes extracted from the peripheral serum of AMI patients on angiogenesis and elucidated the downstream pathways. Patients and Methods: Serum exosomes were obtained from patients with AMI (AMI-Exo) and healthy individuals (Con-Exo). The exosomes were cocultured with human umbilical vein endothelial cells (HUVECs) in vitro, with aortic rings ex vivo, and were used to treat mouse hind-limb ischemia and mouse AMI model in vivo. Results: AMI-Exo raised HUVEC proliferation, tube formation, and migration, and enhanced microvessel sprouting from aortic rings compared to Con-Exo, both in vitro and ex vivo. Quantitative reverse transcription-polymerase chain reaction revealed that the abundance of miR-126-3p, a crucial regulator of angiogenesis, was increased in AMI-Exo. The inhibition of miR-126-3p decreased the benefits of AMI-Exo treatment, and miR-126-3p upregulation enhanced the benefits of Con-Exo treatment in HUVECs, aortic rings, the mouse hind-limb ischemia model, and the mouse AMI model. Knockdown and overexpression analyses revealed that miR-126-3p regulated angiogenesis in HUVECs by directly targeting tuberous sclerosis complex 1 (TSC1). Moreover, we found that miR-126-3p could inhibit TSC1 expression, which further activated mTORC1 signaling and increased HIF-1α and VEGFA expression, ultimately promoting angiogenesis. Conclusion: Collectively, our results provide a novel understanding of the function of exosomes in angiogenesis post AMI. We demonstrated that exosomes from the peripheral serum of AMI patients promote angiogenesis via the miR-126-3p/TSC1/mTORC1/HIF-1α signaling pathway. Keywords: acute myocardial infarction, angiogenesis, exosomes, miR-126-3p, tuberous sclerosis complex 1 Cardiovascular diseases (CVDs) pose immense health and economic burdens worldwide, and account for 44% of all disease-related deaths in China. 1 Acute myocardial infarction (AMI) is the leading cause of death from CVDs. Although thrombolytic anticoagulant therapy and percutaneous coronary intervention can largely restore occluded coronary perfusion after AMI, they cannot repair the damage caused to microvascular architecture in ischemic myocardium by coronary hypoxic ischemia. Angiogenesis is a complex process of vascular endothelial cell proliferation, migration, and branching that forms new microvessels from existing vessels in response to various factors. Since angiogenesis plays an important role in improving myocardial function after AMI, 2 it is necessary to explore the underlying mechanisms and identify effective new therapeutic targets. Exosomes are a type of extracellular microvesicle, with diameters ranging from 30 nm to 150 nm. They contain all kinds of functional biomolecules (DNA, mRNAs, lipids, proteins, and microRNAs [miRNAs]) that can be transferred to nearby or distant cells via the circulatory system. 3 Previous studies have shown that plasma exosomes derived from adult rats and humans can protect the myocardium from ischemia-reperfusion injury by delivering endogenous protective signals to the myocardium. 4 In addition, it has been reported that cardiomyocytes from mice with ischemic injur -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology